CROM Grand Rounds – May 9, 2017 – Making the leap from a clinical series to evidence based medicine to reduce health impacts of RF (radio frequency) – iris Udasin, MD

Posted at 8:46 am May 8, 2017, in Seminars

Speakers: Iris Udasin, MD                

Topic: “Making the leap from a clinical series to evidence based medicine to reduce health impacts  of RF (radio frequency)”

Date and Time: Tuesday, May 9, 2017

Location: Conference Rooms A&B, EOHSI, Piscataway, NJ

OBJECTIVES:

  1. Review concepts of exposure assessment as used in high level acute exposures vs low level chronic exposures
  2. Compare study design issues in different type of exposure and understand the limitations
  3. Use of evidence based medicine to influence the health care community and the public to decrease exposure to RF

 

Target Audience:: Environmental and/or occupational medicine practitioners, community health workers, industrial hygienists, researchers, students of air pollution health effects and to others in the field of environmental and occupational safety and health. Occupational Physicians, Nurses, Industrial Hygienists, fellows, residents, medical students and environmental exposure scientists.

Accreditation & Designation

Rutgers Biomedical and Health Sciences is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for the Healthcare Team.

Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Declarations

Iris Udasin, MD has no relevant financial relationships and Dr.Udasin does not intend to discuss unapproved/investigational uses of commercial products during her presentation.

“Planning committee members, Dr. Mitchel Rosen and Dr. Michael Gochfeld have no relevant financial relationships. Dr. Michael Pratt’s immediate family works for Novartis.”